Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02931175 · ClinicalTrials.gov registry record · Phase 2
ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)
A Phase 2 study, sponsored by Quan Dong Nguyen.
- Completed
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT02931175 is a Phase 2 study that has completed, run by Quan Dong Nguyen. The registered enrollment target is 28 participants.
The verdict
NCT02931175, a Phase 2 study, has completed, sponsored by Quan Dong Nguyen.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
The study aims to evaluate the potential role of ACTH gel in the management of non-infectious uveitis.
Interventions
- DRUG ACTH gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-11-10 |
| Est. Completion | 2021-10-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02931175
The ClinicalTrials.gov registry entry for NCT02931175 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Quan Dong Nguyen, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ACTH gel is the first listed.
NCT02931175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02931175 about?
NCT02931175 is a clinical study titled "ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)". The study aims to evaluate the potential role of ACTH gel in the management of non-infectious uveitis.
What is the current status of trial NCT02931175?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2017-11-10. Estimated completion is 2021-10-28.
What interventions are being tested in trial NCT02931175?
The interventions under investigation include: ACTH gel (DRUG).
Who is sponsoring clinical trial NCT02931175?
This trial is sponsored by Quan Dong Nguyen, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.